Target intelligence / Profile preview

TATA-box binding protein associated factor, RNA polymerase I subunit D (TAF1D)

Target
TAF1D
Molecular classification
Transcription factor, General transcription machinery, Component of the SL1/TIF-IB complex
01

Overview

TATA-box binding protein associated factor, RNA polymerase I subunit D (TAF1D), is a component of the SL1/TIF-IB complex required for RNA polymerase I transcription initiation and ribosomal RNA synthesis. TAF1D localizes to the nucleolus and is essential for the assembly of the preinitiation complex at rDNA promoters. Loss or downregulation of TAF1D impairs SL1 complex recruitment, reduces Pol I transcription, inhibits cell proliferation, and induces cell cycle arrest. TAF1D has emerged as a biomarker of poor prognosis in several cancers, particularly osteosarcoma and MYCN-amplified neuroblastoma, where it regulates G2/M phase-related genes. As such, TAF1D is considered a promising therapeutic target in malignancies associated with altered ribosome biogenesis or cell cycle control

Other names
TAF(I)41RAFI41JOSD3TAFI41TATA box binding protein (TBP)-associated factor, RNA polymerase I, D, 41kDaRNA polymerase I-specific TBP-associated factor 41 kDaTranscription initiation factor SL1/TIF-IB subunit D
02

Mechanism of action

Inhibition of TAF1D reduces RNA polymerase I recruitment and rRNA synthesis, leading to cell cycle arrest (notably at G2/M) and reduced cell proliferation

03

Biological functions

Transcription initiation by RNA polymerase IRibosomal RNA (rRNA) synthesisCell cycle regulationNucleolar preinitiation complex assemblyCell proliferation
04

Disease associations

Cancer (notably osteosarcoma, neuroblastoma, breast, ovarian, cervical, skin, pancreatic, lung, and stomach cancers)Biomarker in osteosarcoma and intervertebral disc degeneration
05

Safety considerations

Potential challenges in targeting core transcriptional machinery due to off-target effects on essential cell functionCriticality for ribosome biogenesis may limit therapeutic window
06

Interacting drugs

NU.1025 (investigational, predicted)
07

Biomarkers

Overexpression of TAF1D (mRNA/protein) in tumors as a poor prognosis markerTAF1D as a marker for osteosarcoma and intervertebral disc degeneration

Beyond the preview

Go deeper on TATA-box binding protein associated factor, RNA polymerase I subunit D (TAF1D).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TATA-box binding protein associated factor, RNA polymerase I subunit D (TAF1D).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call